CT83 and breast cancer: Conversely, the abnormal activation of CT83 is often detected in cancer tissues including breast cancer, and its high expression is statistically different from paired normal tissues in lung adenocarcinoma (LUAD) and stomach adenocarcinoma (STAD) tissues.